Provided by Tiger Trade Technology Pte. Ltd.

Charles River Laboratories

174.46
-6.8600-3.78%
Post-market: 174.460.00000.00%19:33 EST
Volume:1.08M
Turnover:189.07M
Market Cap:8.59B
PE:-59.91
High:179.86
Open:178.89
Low:172.92
Close:181.32
52wk High:228.88
52wk Low:91.86
Shares:49.22M
Float Shares:48.62M
Volume Ratio:1.14
T/O Rate:2.22%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.9122
EPS(LYR):-2.9122
ROE:-4.23%
ROA:4.24%
PB:2.71
PE(LYR):-59.91

Loading ...

Charles River Exec Says It Will Take 1-2 Quarters to See Benefit of Stronger 4Q25 Booking

THOMSON REUTERS
·
Feb 18

Charles River forecasts upbeat 2026 profit on improved demand for drug development services

Reuters
·
Feb 18

Charles River Q4 revenue slightly beats expectations

Reuters
·
Feb 18

BRIEF-Charles River Laboratories Announces Executive Appointments

Reuters
·
Feb 18

GUIDANCE: (CRL) Charles River Laboratories Expects 2026 Adjusted EPS Range $10.70 - $11.20, vs. FactSet Est of $11

MT Newswires Live
·
Feb 18

Charles River Laboratories names Glenn Coleman CFO and Kerry Dailey Chief Legal Officer

Reuters
·
Feb 18

Charles River (CRL) posts Q4 GAAP operating margin -28.5% on USD 994.23M revenue (-0.8%)

Reuters
·
Feb 18

Charles River Laboratories International Inc - Appoints Glenn Coleman as CFO

THOMSON REUTERS
·
Feb 18

BRIEF-Charles River Q4 Adjusted EPS USD 2.39 Vs. IBES Estimate USD 2.34

Reuters
·
Feb 18

Charles River Laboratories Announces Fourth-Quarter and Full-Year 2025 Results and Provides 2026 Guidance

THOMSON REUTERS
·
Feb 18

Charles River Q4 EPS USD -5.62

THOMSON REUTERS
·
Feb 18

Charles River Laboratories International Inc Outlook 2026 Revenue Growth at Least Flat to +1.5%

THOMSON REUTERS
·
Feb 18

Charles River Outlook FY Adjusted EPS USD 10.7-11.2

THOMSON REUTERS
·
Feb 18

Charles River Laboratories International Inc. Stock Outperforms Competitors Despite Losses On The Day

Dow Jones
·
Feb 18

Top News Today: Stocks Rise, Oil Falls as Iran Tensions Subside

Dow Jones
·
Feb 18

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Feb 17

FDA Delays Disc Medicine's Rare Disease Drug

Benzinga_recent_news
·
Feb 17

Disc Medicine Receives Complete Response Letter from FDA for Bitopertin for the Treatment of EPP

GlobeNewswire
·
Feb 14

Charles River Laboratories International Inc. Stock Underperforms Thursday When Compared To Competitors

Dow Jones
·
Feb 13

Charles River Laboratories International Inc. Stock Slides 8.4%, Underperforms Peers

Dow Jones
·
Feb 12